National Institute of Cardiology
Rio de Janeiro, 21040-360, Brazil
NCT Number: NCT03243045
It has been proposed that the modulation of the activity of the sympathetic nervous system, through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vascular reactivity and consequent improvement of macro and microcirculation.
The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients presenting with resistant arterial hypertension.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Rio de Janeiro, 21040-360, Brazil
Arterial hypertension is still a serious public health problem with considerable social and economic impact. Arterial hypertension is the result from a complex interaction between environmental and genetic factors that initiate and perpetuate elevated blood pressure. Studies show that about 10% of patients undergoing treatment have resistant hypertension, defined as high blood pressure refractory to at least three antihypertensive drugs. It is known that the sympathetic nervous system plays a fundamental role in the pathophysiology of hypertension, contributing to metabolic and vascular changes. The sympathetic nervous system has also a major role in the pathophysiology of arterial hypertension. Arterial hypertension has also been associated with functional microcirculatory alterations as well as systemic microvascular endothelial dysfunction in hypertensive patients, confirmed by different microcirculatory flowmetry techniques. In this context, it has been proposed that the modulation of the sympathetic nervous system through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vascular reactivity and consequent improvement of macro and microcirculation.
The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients with resistant hypertension.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transcutaneous renal sympathetic denervation
Time frame: Before and one, three, six and twelve months after intervention
Evaluation of microvascular reactivity using laser speckle contrast imaging
Time frame: Before and one, three, six and twelve months after intervention
Evaluation of the microvascular flow using laser speckle contrast imaging
Time frame: Before and one, three, six and twelve months after intervention
Evaluation of cutaneous capillary density and reactivity using video-capillaroscopy
National Institute of Cardiology, Laranjeiras, Brazil
Other Gov
Evaluation of Systemic Microvascular Density and Endothelial Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07709962
Arterial Hypertension, Cardiovascular Diseases
Rijeka, Croatia
View Trial DetailsNCT06428825
Arterial Hypertension, Cardiovascular Diseases
Mannheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT05464849
Arterial Hypertension, Cardiovascular Diseases
Rio de Janeiro, Brazil
View Trial DetailsNCT06916923
Arterial Hypertension, Balance
Istanbul, Turkey (Türkiye)
View Trial Details